Research Article / Open Access
DOI: 10.31488/bjg.1000116
Comparison of Spraying and Nebulized Lidocaine in Patients Undergoing Esophago-Gastro-Duodenoscopy: A Randomized Trial
Papiroon Noitasaeng B.NS*1, Phongthara Vichitvejpaisal MD, PhD1, Uayporn SiriyuyuenMD2, Tassanee Jaiyen, B.NS1,Suwannee Siriwongsa, B.NS3
Department of Anaesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Department of Perioperative NursingFaculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
*Corresponding author: PhongtharaVichitvejpaisal MD, PhD,Department of Anaesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Abstract
Objective:Esophago-gastro-duodenoscopy(EGD) was performed under the topical anesthesia of the pharynx. However, spraying lidocainewasfound to be an annoying maneuver to patients, while nebulized lidocaine appeared to efficiently suppress gags and cough reflexes in the airway. Investigators compared the effectiveness of spraying and nebulized lidocaine for patients undergoing EGD. Material and Method:A total of 110 patients undergoing elective EGD, with a history of neitherlidocaine intolerance nor irritable airways due to smoking,chronic obstructive pulmonary disease (COPD), upper respiratory infection, asthma, cardiac and pulmonary diseases and allergy to lidocainewere included. All patients were randomized into two groups: A – where 5 puffs (10mg/puff) of spraying lidocainewere administered four times at 5-minute intervals, up to a total dose of 200mg;and B–where 250 mg of nebulized lidocainewas administered via a nebulization kitwith an oxygen face mask of 7 LPM for 15 minutesprior to the commencement of EGD. The procedure was performed by the same board-certified endoscopist. The co-researcher who was blinded to the technique assessed the ease of esophageal instrumentationas either difficult, poor, fair or excellent. Both the endoscopist and the patients expressed their satisfaction by using the Numerical Rating Scale. Results: The endoscopist expressed her satisfaction with instrumentation, which showed significant difference between group A and group B as 84.8±8.3 and 79.2±11.2,respectively.The co-researcher also found that group A patients responded to the ease of esophageal instrumentation better than those in group B. However, nebulized lidocaine had significant advantages over spraying lidocaine, with better acceptance in patients undergoing EGD.Conclusion: The endoscopist expressed her approval of spraying lidocainefor taking less time to start the procedure, ease for instrumentation, less gag reflex during the procedure, less presence of hypersecretion, and smooth operation. However, participantsfavored nebulized lidocaine administration.
Keywords: anaesthetic technique-topical, esophago-gastro-duodenoscopy.
Introduction
Endoscopy of the upper alimentary tract is an invasive technique resulting in gag reflex, bradyarrhymiasand unpleasant symptoms in patients. In practice,esophago-gastro-duodenoscopy(EGD) is performed under the topical anaesthesia of the pharynxor parenteral administration of sedative drugs[1-6], or both. Topical lidocaine plays a crucial role in accomplishing this assignment because it yields a rapid onset with a high safety margin. The successful criteria of the procedure under local anaesthesia are not only safety and simplicitybut also provides adequate anaesthesia.
Sprayinglidocainewas broadly accepted as a simple technique becauseof rapid onset. It might produce an unexpectedly stressful reflex with pain during swallowing [7, 8].Moreover, the efficacy of lidocaineappeared to decrease in cases of patient’s hypersecretion or anatomical variability as well as quick swallowing of the drug [4].Thus, anaesthesia personnel should be aware oftheir practical skills and desire to gain more knowhow [10, 11].
Nebulized lidocaine has long been claimed for its medical usefulness in many modalities without any complications, or patient discomfort [12-14].Though lidocaine has a very low blood level because of nebulization, it dramatically decreases systemic pain [14-16]. Interestingly, nebulized lidocaine appeared efficient in suppressing gags and cough reflexes as well as airway anaesthesia [12, 14, 17, 18].
This study aimed to comparison of the effectiveness; successful completion of the endoscopic procedure of spraying and nebulized lidocainefor patients undergoing EGD.
Materials and Methods
The prospective randomized study was approved by Siriraj Institutional Review Board (Si-IRB), COA: Si534/2013 (17/09/2013), and was written informed consent was obtained from all subjects. Study setting wasregistered at ClinicalTrials.gov, NCT02317770(12/11/2014). The study was conducted at the Department of Siriraj Gastro-Intestinal Endoscopy Center.
Patients
A total of 110 patients were enrolled in the study between September 2013 and August 2015.Inclusion criteria were patients aged between 18 and 65,underwent elective EGD, American Society of Anaesthesiologist (ASA) physical status class I/II, without a history of lidocaine intolerance,and able to complete questionnaires.
Exclusion criteria were patients with irritable airwaysdue to smoking, chronic obstructive pulmonary disease (COPD), upper respiratory tract infection, or asthma, cardiac or pulmonary diseases, and allergy to lidocaine.
Withdrawal or termination criteria were patients’ refusal to continue under the study, bronchospasm, signs of lidocaine overdose ortoxicity including tinnitus, light-headedness, circum-oral numbness, visual disturbances, involuntary muscle spasm, convulsions, cardiac depression, and cardiac arrest [19].
At the Endoscopy Center.
All patients were randomized into two groupsby using a computerprogram andclosed envelopes as A-spraying lidocaine and B–nebulized lidocaine.
Intervention
In group A, the co-researcher administeredfive puffs of spraying lidocaine (10mg/puff) four times at 5-minute intervals, up to the total dose of 200mg. The drug was sprayed at the tonsils, anterior pillars, and base of tongue.
In group B, patients in the semi-sitting position received 250mg of nebulized lidocaine via a nebulization kit(Hudsons, Aerosol nebulizer mask with tubing, supplied by Bever Medical Industry, Co., Ltd.,Thailand)with 7 liter per minute (LPM)of oxygen via face mask for 15 minutes.
The administration of lidocaine in both groups was finishedfive minutes before the start of EGD. A supplementaloxygen (3 LPM) via nasal cannula was administered to all patients who had already been monitored with standard monitoring. The procedure was performed by oneboard-certifiedendoscopist who conducted more than 1,000 cases of EGD annually.
During procedure, the co-researcher who was blinded to the lidocaine administration technique assessed the ease of esophageal instrumentation as following [20]; difficult, poor, fair or excellent.
Step 1 = Difficult for esophageal instrumentation was defined aspatient refused esophageal instrumentation.
Step 2 = Poor was defined as patient had gag reflex and needed sedation.
Step 3 = Fair was defined as patient had mild gag reflex.
Step 4 = Excellent was defined as patient had no gag reflex.
After the procedure, the endoscopistassessed the ease of esophageal instrumentation by using the Numerical Rating Scale (NRS: 0-100), with 0 being difficult and 100 being easy. In addition, she expressed her satisfaction with thelidocaine administration technique by using the NRS 0-10with 0 being dissatisfied and 10 being satisfied; the topics of time to start the procedure;instrumentation technique; gag reflexes during the procedure; presence of hypersecretion; and smooth operation.
The patients weredelivered to the recovery room for 1-hourobservation of vital signs and other complications under the guidelines ofthe Siriraj Gastro-Intestinal Endoscopy Center.Before discharge, the co-researcher interviewed the patients usingthe questionnairesfor their satisfactionwith the topical anaesthesia techniquesby using NRS 0-10, with 0 being dissatisfied and 10 being very satisfied.
Statistical analysis
The study was designed to test the clinical hypothesis that topical anaesthesia with nebulized lidocaine was as effective as sprayinglidocaine in patients undergoing EGD. The data were expressed as mean and standard deviation. The categorical variables were carried out using the Chi-square test. The interval variables between the two groupssuch as NRSwere compared using the independent t-test. Finally, p-value less than 0.05 with 95% confidence interval was considered statistically significant difference.
Results
Demographic data including sex, age, weight, height, ASA physical status, allergy, history of EGD and/or EGD under anaesthetic technique were not significant differences between thetwo groups (Table 1). One hundred and ten patients were equally randomized into two groups. Three patients were excluded from the study: one in group A was dropped out due to the extended protocol, and other two in group B due to the incidence of bronchospasm and recall of upper respiratory tract infection.
Table 1. Patients’demographic data between the spraying and nebulized lidocaine groups.
GroupA (n=54) |
GroupB (n=53) |
P-value | |
---|---|---|---|
Age (yr) | 51.80(10.84) | 49.60(11.37) | 0.3 |
Sex (M:F) | 19:35 | 23:30 | 0.4 |
Weight (kg) | 57.610.49) | 58.89(12.25) | 0.6 |
Height(cm) | 160.64(8.22) | 161.64(8.86) | 0.5 |
ASA physical status,n(%) 1 2 |
19(35.2) 35(64.8) |
23(43.4) .30(56.6) |
0.4 |
Allergy, n (%) none drugs food drugs and food |
45(83.3) 6(11.1) 2(3.7) 1(1.9) |
48(90.6) 4(7.5) 1(1.9) 0 (0) |
0.6 |
History of EGD, n (%) none once more than one |
28(51.9) 19(35.2) 7 |
32(60.4) 15(28.3) 6(11.3) |
0.7 |
History of EGD under anaesthetic technique, n (%) none spraying lidocaineIV sedation spraying lidocaine and IV sedation |
28(51.9) 19(35.2) 4(7.4) 3(5.6) |
32(60.4) 15(28.3) 4(7.5) 2(3.8) |
0.8 |
EGD = Esophago-Gastro-Duodenoscopy
Data are expressed as n(%)
The endoscopist expressed to theprocedural effectiveness: satisfactionscorewith instrumentation, which showedsignificant differencebetween group A and group B as 84.8±8.3 and 79.2±11.2respectively and so does the co-researcher as the NRS(Table 2).
Patients’response | GroupA (n=54) |
GroupB (n=53) |
P-value | |
---|---|---|---|---|
Endoscopist | 84.8±8.3 | 79.2±11.2 | 0.004 | |
Co-researcher | difficult | 0(0) | 0(0) | |
poor | 1(1.9) | 4(7.5) | ||
fair | 27(50) | 40(75.5) | ||
excellent | 26(48.1) | 9(17.0) |
Table 2.The endoscopist and the co-researcher assessed the procedural effectiveness under the numerical rating scale (mean±SD) and number of patients’ response n (%) in consequence.
The endoscopistcommended group Apatients for taking less time to start the procedure, ease for instrumentation, less gag reflexes during the procedure, less presence of hypersecretion, and smooth operation (Table 3).
In group A, participants showed the sensation during instrumentation better than group B and performed equal physical feeling during drug administration. However, for other categories, sensation after drug administration, willingness for drug administration, incidence of sore throat and dysphagia, Group B performed better than group A. Patients still chose either spraying or nebulized lidocaine for EGD (Table 3).
Evaluator | Topic | GroupA (n=54) |
GroupB (n=53) |
P-value |
---|---|---|---|---|
Endoscopist | time to start the procedure | 9.1(0.6) | 8.7(1.2) | 0.051 |
instrumentation technique | 8.5(1.0) | 7.4(1.7) | 0.000* | |
gag reflex during the procedure | 8.4(1.2) | 7.3(1.8) | 0.000* | |
presence of hypersecretion | ||||
smooth operation | 8.2(0.8) | 8.0(0.9) | 0.269 | |
Participants | sensation during drug administration | 8.2(1.9) | 8.2(1.7) | 0.863 |
taste of medication | 7.7(2.0) | 7.9(1.9) | 0.623 | |
sensation during the instrumentation | 7.7(2.1) | 7.4(1.8) | 0.426 | |
sensation after drug administration | 8.3(1.6) | 8.9(1.0) | 0.010* | |
willingness for drug administration | 8.4(1.7) | 8.8(1.3) | 0.127 | |
sore throat | 8.6(1.6) | 9.1(1.4) | 0.056 | |
dysphagia | 8.6(1.8) | 9.3(1.3) | 0.039* | |
Treatment of choice [n (%)] | yes | 52(96.3%) | 51(96.2%) | |
no | 2(3.7%) | 2(3.8%) |
Table 3. The endoscopist’s satisfaction score with the operation and participants’ satisfaction score with the drug administration.
Discussion
In view of the endoscopist’s satisfaction, spraying lidocaine was more effective for the instrumentation than nebulizedlidocaine. We found that patients in the nebulized group responded as “fair” more often than that in the spraying group; however, the responses were not “poor” and “excellent”. On the other hand, patients showed receptiveness to nebulized lidocaine administration
.In the current study, spraying lidocaine seemed to be a practical maneuver for the surgeon to deal with the patients during the procedure. This finding is well-accepted by many operators.Korttila K. et al (1981) administered spraying lidocaine and ultrasonic nebulization in patients underwent bronchoscopy and found that spraying lidocaine was more efficient than ultrasonic nebulization [14]. Hedenbro JL. et al (1992) claimed that after topical anaesthesia of the pharynx with spraying lidocaine, endoscopists expressed less discomfort from the intubation and satisfied with the technique [21]. Somchai A. et al (2009) studied patients undergoing EGD using viscous and spraying lidocaine and found that spraying lidocaineled to better tolerance and ease of intubation as well as high patients’ satisfaction and pain scores [20]. However, spraying lidocainecarries some adverse effects. It can cause discomfort among patients needing to open their mouths widely while the drug is sprayed over the surrounding areas. Hsin-I Tsai et al. (2012) studied patients under moderate to deep sedation for diagnostic gastroscopy and found that topical pharyngeal anaesthesia with lidocaine yielded an irritating sensation and a bitter taste to patients [7]. Dhir V. et al. (1997) compared lidocainewith placebo in unsedated patients undergoing EGD and claimed that the spraying lidocaine did not ease the procedure [4]. Because of the difficulty of spraying lidocaine over the mucosa or the presence of saliva, or because patients swallowed the drug immediately, the pharynx was only partially anaesthetized [4]. Also, Fresh AC. el al. (1998) stated that their patients experienced a bad taste after lidocaine spraying [8].
It is therefore not surprising that nebulized lidocaine was well-accepted, since the technique is familiar (oxygen administration via face mask). Williams KA. et al. (2005) used nebulized lidocaine in unsedated patients for awake fiber-optic intubation and claimed thatlidocaine nebulization was acceptable among patients [19]. Keane D. et al. (1992) stated that nebulized lidocaine had significant advantages over spraying lidocaine,with better acceptance in patients undergoing fiber-optic bronchoscopy [22]. Therefore, it was a convenient, well-tolerated method of drug delivery for upper airway endoscopy [9].
However, Korttila K. et al. (1981) noted that it was difficult to determine the exact dosage of inhaledlidocaine [14]. This might agree with many researchers who claimed that up to 60% of lidocainewaslost to the atmosphere or in patients’ mouth during the nebulization [16, 23, 24].As a result, it was not easy to figure out the dosage of nebulized lidocaine to alleviate the discomfort during instrumentation. Thus, it became an advantage to decrease the incidence of systemic adverse effects due to its serum level was remarkably low [9, 12, 25, 26].
Conclusion
For the EGD, spraying lidocaine was dramaticallymore effectivethan nebulized lidocaine. However, patients expressed more satisfaction with nebulized lidocaine administration during the instrumentation.
Acknowledgement
Firstly, I would like to express my sincere gratitude to my advisor andcorresponding author Prof.Dr. Phongthara Vichitvejpaisal for his patience, motivation, enthusiasm, and immense knowledge in this research, His guidance helped me in all the time of research and writing of this paper. I could not have imagined having a better advisor and mentorfor my study.Besides my advisor, I very much appreciatedDepartment of Anaesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University for giving me this opportunity. I would like to thank R2R : Routine to Researchforfunding support this research.
References
1. Ristikankare M, Hartikainen J, Heikkinen M, et al. Is routine sedation or topical pharyngeal anaesthesia beneficial during upper endoscopy? Gastrointestinal endoscopy.2004; 60: 686-94.
2. Sorbi D, Chak A. Unsedated EGD. GastrointestEndosc. 2003; 58: 102–10.
3. Fisher NC, Bailey S, Gibson JA. A prospective randomized controlled trial of sedation vs no sedation in outpatient diagnostic endoscopy.Endoscopy.1998; 30: 21–4.
4. Dhir V, Swaroop VS, Vazifdar KF, Wagle SD. Topical pharyngeal anesthesia without intravenous sedation during upper gastrointestinal endoscopy. Indian J Gastroenterol 1997 Jan; 16(1): 10-1.
5. Jameson JS, Kapadia SA, Polsen RJ. Oropharyngeal Anaesthesia with Topical Lignocaine Useful in Upper Gastrointestinal Endoscopy.Ailmentary Pharmacology and Therapeutics 1992; 6: 739-44.
6. Early DS, Lightdale JR, Vargo JJ, et al. Guidelines for sedation and anesthesia in GI endoscopy. GastrointestEndosc.2018; 87(2): 327-337.
7. Tsai HI, Tsai YF, Liou SC, et al. The Questionable Efficacy of Topical Pharyngeal Anesthesia in Combination with Propofol Sedation in Gastroscopy. Dig Dis Sci. 2012; 57: 2519-26.
8. Frosh AC, Jayaraj S, Porter G, et al. Is local anaesthesia actually beneficial in flexible fiberopticnasendocopy? ClinOtolaryngol. 1998; 23: 259-62.
9. Shirk MB, Donahue KR, Shirvani J. Unlabeled uses of Nebulized Medications. Am J Health Syst Pharm. 2006; 63: 1704-16.
10. Arrowsmith JB, Gerstman BB, Fleischer DB, et al. Result from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy.GastrointestEndose. 1991; 37: 421-7.
11. Daneshmend TK, Bell GD, Logan RFA. Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut. 1991; 32: 12-5.
12. Gjonaj ST, Lowenthal DB, Dozor AJ. Nebulized lidocaine administered to infants and children undergoing flexible bronchoscopy. Chest. 1997; 112: 1165-9.
13. Rolando B, John WM, Barbara P, et al. Safety and efficacy of using high-dose topical and nebulized anaesthesia to obtain endobronchial cultures. Chest. 1989; 95(2): 299-303.
14. Korttila K, TarkkanenJ, Tarkkanen L. Comparison of laryngotracheal and ultrasonic nebulizer for administration of lidocaine in local anaesthesia for bronchoscopy. ActaAnestScand. 1981; 25: 161-5.
15. Spektor M, Kaplan J, Kelley J, et al. Nebulized or sprayed lidocaine as anaesthesia for nasogastric intubations. AcadEmerg Med. 2000; 7: 406-8.
16. Chinn WM, Zavala DC, Ambre J. Plasma level of lidocaine following nebulized aerosol administration. Chest. 1977; 71(3): 346-8.
17. Kirkpatrick MB, Sandras RV, Bass JB. Physiologic effects and serum lidocaine concentrations after inhalation of lidocaine from a compressed gas-powdered jet nebulizer.Am Rev Respir Dis. 1987; 136: 447-9.
18. Gove RI, Wiggins J, Stableforth DE. A study of the use of ultrasonically nebulized lignocaine for local anaesthesia during fiberoptic bronchoscopy. Br J Dis Chest. 1985; 79: 49-59.
19. Williams KA, Barker GL, Harwood RJ, et al. Combined nebulization and spray-as-you-go topical local anaesthesia of the airway. BrJ Anaesth. 2005; 95: 549-53.
20. Amornyotin S, Srikureja W, Chalayonnavin W, et al. Topical viscous lidocaine solution versus lidocaine spray for pharyngeal anaesthesiaunsedated esophagogastroduodenoscopy. Endoscopy. 2009; 41: 581-86.
21. Hedenbro JL, Ekelund M, Jansson O, et al. A randomized, double-blind, placebo-controlled study to evaluate topical anaesthesia of the pharynx in upper gastrointestinal endoscopy.Endoscopy. 1992; 24: 585-7.
22. Keane D, Mcnicholas WT. Comparison of nebulized and sprayed topical anaesthesia for fiberoptic bronchoscopy. EurRespir J 1992; 5: 1123-5.
23. Christoforodis AN, Tomashefski JF, Mitchell RI. Use of an ultrasonic nebulizer for the application of oropharyngeal, laryngeal and tracheobronchial anaesthesia. Chest 1971; 59: 629.
24. Gomez F, Barrueco M, Lanao JM,et al. Dominguez-Gil A. Serum lidocaine levels in patients undergoing fibrobronchoscopy. Ther Drug Monit. 1983; 5: 201-03.
25. Palve T, Jokinen K, Saloheimo M, et al. Ultrasonic nebulizer in local anaesthesia for bronchoscopy. Oto- Rhino- Laryngol. 1975; 37: 306-311.
26. Parkes SB, Butler CS, Muller R. Plasma lignocaine concentration following nebulization for awake intubation. AnaesthIntens Care. 1997; 25: 369-71
Received: May 04, 2020;
Accepted:June 02, 2020;
Published: June 04, 2020.
To cite this article : Noitasaeng P,Vichitvejpaisal P,Siriyuyuen U, et al.Comparison of Spraying and Nebulized Lidocaine in Patients Undergoing Esophago-Gastro-Duodenoscopy:A Randomized TrialBritish Journal of Gastroenterology. 2020; 2:3.
©Noitasaeng P,et al.2020..